Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Qing Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1094-3515; OpenAlex author ID A5044350856. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Is new risk-assessment score of venous thromboembolism for hospitalized surgical patients with borderline resectable pancreatic adenocarcinoma needed? Co-author DOI 10.1016/j.asjsur.2022.10.052↗
  2. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. Co-author DOI 10.1155/2022/5514715↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Songping Cui · 1 shared paper, 2023 · strength 0.26
  2. Ren Lang · 1 shared paper, 2023 · strength 0.26
  3. Junming Xu · 1 shared paper, 2022 · strength 0.15
  4. Xinxue Zhang · 1 shared paper, 2022 · strength 0.15
  5. Xin Zhao · 1 shared paper, 2022 · strength 0.15
  6. Qiang He · 1 shared paper, 2022 · strength 0.15
  7. Zhangyong Ren · 1 shared paper, 2022 · strength 0.15
  8. Zhe Liu · 1 shared paper, 2022 · strength 0.15
  9. Ren Lang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.